Literature DB >> 26345256

Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agents.

Jie Dong1, Xiaoqing Yu2, Dale W Porter3, Lori A Battelli3, Michael L Kashon4, Qiang Ma5.   

Abstract

Pulmonary fibrosis results from the excessive deposition of collagen fibers and scarring in the lungs with or without an identifiable cause. The mechanism(s) underlying lung fibrosis development is poorly understood, and effective treatment is lacking. Here we compared mouse lung fibrosis induced by pulmonary exposure to prototypical particulate (crystalline silica) or soluble chemical (bleomycin or paraquat) fibrogenic agents to identify the underlying mechanisms. Young male C57BL/6J mice were given silica (2 mg), bleomycin (0.07 mg), or paraquat (0.02 mg) by pharyngeal aspiration. All treatments induced significant inflammatory infiltration and collagen deposition, manifesting fibrotic foci in silica-exposed lungs or diffuse fibrosis in bleomycin or paraquat-exposed lungs on day 7 post-exposure, at which time the lesions reached their peaks and represented a junction of transition from an acute response to chronic fibrosis. Lung genome-wide gene expression was analyzed, and differential gene expression was confirmed by quantitative RT-PCR, immunohistochemistry, and immunoblotting for representative genes to demonstrate their induced expression and localization in fibrotic lungs. Canonical signaling pathways, gene ontology, and upstream transcription networks modified by each agent were identified. In particular, these inducers elicited marked proliferative responses; at the same time, silica preferentially activated innate immune functions and the defense against foreign bodies, whereas bleomycin and paraquat boosted responses related to cell adhesion, platelet activation, extracellular matrix remodeling, and wound healing. This study identified, for the first time, the shared and unique genes, signaling pathways, and biological functions regulated by particulate and soluble chemical fibrogenic agents during lung fibrosis, providing insights into the mechanisms underlying human lung fibrotic diseases.

Entities:  

Keywords:  Bleomycin; Genome-wide gene expression; Inflammation; Paraquat; Pulmonary fibrosis; Silica

Mesh:

Substances:

Year:  2015        PMID: 26345256      PMCID: PMC4749430          DOI: 10.1007/s00204-015-1589-3

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  44 in total

Review 1.  SLPI and inflammatory lung disease in females.

Authors:  Paul J McKiernan; Noel G McElvaney; Catherine M Greene
Journal:  Biochem Soc Trans       Date:  2011-10       Impact factor: 5.407

Review 2.  SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.

Authors:  Marie-Louise Zani; Annabelle Tanga; Ahlame Saidi; Hélène Serrano; Sandrine Dallet-Choisy; Kévin Baranger; Thierry Moreau
Journal:  Biochem Soc Trans       Date:  2011-10       Impact factor: 5.407

Review 3.  Progress toward improving animal models for idiopathic pulmonary fibrosis.

Authors:  Amber L Degryse; William E Lawson
Journal:  Am J Med Sci       Date:  2011-06       Impact factor: 2.378

4.  Genetic linkage analysis of pulmonary fibrotic response to silica in mice.

Authors:  Y Ohtsuka; X-T Wang; J Saito; T Ishida; M Munakata
Journal:  Eur Respir J       Date:  2006-07-12       Impact factor: 16.671

5.  Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice.

Authors:  Roderick J Tan; Cheryl L Fattman; Laura M Niehouse; Jacob M Tobolewski; Lana E Hanford; Qinglang Li; Federico A Monzon; William C Parks; Tim D Oury
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-30       Impact factor: 6.914

6.  Tenascin-C deficiency attenuates TGF-ß-mediated fibrosis following murine lung injury.

Authors:  William A Carey; Glen D Taylor; Willow B Dean; James D Bristow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-10       Impact factor: 5.464

Review 7.  Murine models of pulmonary fibrosis.

Authors:  Bethany B Moore; Cory M Hogaboam
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

8.  A brief review of silicosis in the United States.

Authors:  Carson R Thomas; Timothy R Kelley
Journal:  Environ Health Insights       Date:  2010-05-18

9.  Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes.

Authors:  Dale W Porter; Ann F Hubbs; Robert R Mercer; Nianqiang Wu; Michael G Wolfarth; Krishnan Sriram; Stephen Leonard; Lori Battelli; Diane Schwegler-Berry; Sherry Friend; Michael Andrew; Bean T Chen; Shuji Tsuruoka; Morinobu Endo; Vincent Castranova
Journal:  Toxicology       Date:  2009-10-24       Impact factor: 4.221

10.  Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.

Authors:  Annie Pardo; Kevin Gibson; José Cisneros; Thomas J Richards; Yinke Yang; Carina Becerril; Samueal Yousem; Iliana Herrera; Victor Ruiz; Moisés Selman; Naftali Kaminski
Journal:  PLoS Med       Date:  2005-09-06       Impact factor: 11.069

View more
  17 in total

1.  In vivo activation of a T helper 2-driven innate immune response in lung fibrosis induced by multi-walled carbon nanotubes.

Authors:  Jie Dong; Qiang Ma
Journal:  Arch Toxicol       Date:  2016-04-22       Impact factor: 5.153

2.  TIMP1 promotes multi-walled carbon nanotube-induced lung fibrosis by stimulating fibroblast activation and proliferation.

Authors:  Jie Dong; Qiang Ma
Journal:  Nanotoxicology       Date:  2016-12-09       Impact factor: 5.913

3.  Combination Therapy with Pirfenidone plus Prednisolone Ameliorates Paraquat-Induced Pulmonary Fibrosis.

Authors:  Rokhsana Rasooli; Fatemeh Pourgholamhosein; Younes Kamali; Fatemeh Nabipour; Ali Mandegary
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

4.  Diosmin ameliorative effects on oxidative stress and fibrosis in paraquat-induced lung injury in mice.

Authors:  Sirus Mirzaee; Esrafil Mansouri; Maryam Shirani; Marzieh Zeinvand-Lorestani; Mohammad Javad Khodayar
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-15       Impact factor: 4.223

5.  Autophagy in pulmonary fibrosis: friend or foe?

Authors:  Charlotte Hill; Yihua Wang
Journal:  Genes Dis       Date:  2022-11

Review 6.  Myofibroblasts and lung fibrosis induced by carbon nanotube exposure.

Authors:  Jie Dong; Qiang Ma
Journal:  Part Fibre Toxicol       Date:  2016-11-04       Impact factor: 9.400

7.  Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-β1 activation and myofibroblast differentiation.

Authors:  Jie Dong; Qiang Ma
Journal:  Part Fibre Toxicol       Date:  2017-06-08       Impact factor: 9.400

Review 8.  Type 2 Immune Mechanisms in Carbon Nanotube-Induced Lung Fibrosis.

Authors:  Jie Dong; Qiang Ma
Journal:  Front Immunol       Date:  2018-05-22       Impact factor: 7.561

9.  Oral administration of curcumin ameliorates pulmonary fibrosis in mice through 15d-PGJ2-mediated induction of hepatocyte growth factor in the colon.

Authors:  Yu-Meng Miao; Ya-Jing Zhang; Si-Miao Qiao; Yu-Feng Xia; Zhi-Feng Wei; Yue Dai
Journal:  Acta Pharmacol Sin       Date:  2020-07-21       Impact factor: 6.150

10.  Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis.

Authors:  Hao Sun; Junjie Chen; Wenyi Qian; Jiang Kang; Jun Wang; Lei Jiang; Li Qiao; Wei Chen; Jinsong Zhang
Journal:  J Cell Mol Med       Date:  2016-01-29       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.